bmiMD vs Novi
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Novi
Best for transparent all-in compounded GLP-1 pricingStarting at $174/mo
Side-by-Side Comparison
| Feature | bmiMD | Novi |
|---|---|---|
| Overall Score | 7.1/10 | ✓8.6/10 |
| Starting Price | — | $174/mo |
| Editorial Rating | 3.6 ★ /5 | ✓4.3 ★ /5 |
| Features | 2 features | ✓5 features |
| States Available | ✓50 | 0 |
| Compounded | — | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
bmiMD
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Novi
Pros
- ✓Transparent all-in monthly pricing — medication, clinician support, and shipping bundled with no hidden fees or membership add-ons
- ✓Both compounded semaglutide and tirzepatide available
- ✓Unlimited clinician messaging included at no extra cost
- ✓Free 2-day shipping on every refill
Cons
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗3-month minimum commitment is non-refundable per Terms of Service unless a clinician deems treatment medically inappropriate
- ✗State availability and pharmacy partners not publicly listed — patients learn during intake which states and pharmacies serve them
Our Verdict
Novi edges out bmiMD with a higher overall score of 8.6/10 and is particularly strong for transparent all-in compounded GLP-1 pricing. bmiMD remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.